Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2498
116th Congress(2019-2020)
PACT Act
Introduced
Introduced
Introduced in House on May 2, 2019
Overview
Text
Introduced in House 
May 2, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 2, 2019)
May 2, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2498 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 2498


To amend title XVIII of the Social Security Act to ensure that hospitals receive adequate payment for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

May 2, 2019

Mr. Kind (for himself, Mr. Marchant, Mr. Bilirakis, and Ms. Matsui) introduced the following bill; which was referred to the Committee on Ways and Means

A BILL

To amend title XVIII of the Social Security Act to ensure that hospitals receive adequate payment for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Patient Access to Cellular Transplant Act” or the “PACT Act”.

SEC. 2. Hematopoietic stem cell acquisition payments.

Section 1886 of the Social Security Act (42 U.S.C. 1395ww) is amended—

(1) in subsection (a)(4), in the second sentence, by inserting “for cost reporting periods beginning on or after October 1, 2020, costs related to he­ma­to­poi­et­ic stem cell acquisition for the purpose of an al­lo­ge­ne­ic hematopoietic stem cell transplant (as described in subsection (d)(5)(M)),” after “October 1, 1987),”;

(2) in subsection (d)—

(A) in paragraph (4)(C)(iii)—

(i) by inserting “or payments under paragraph (5)(M) (beginning with fiscal year 2021)” after “fiscal year 1991)”; and

(ii) by inserting “or payments under paragraph (5)(M)” before the period at the end; and

(B) in paragraph (5), by adding at the end the following new subparagraph:

“(M) (i) For cost reporting periods beginning on or after October 1, 2020, in the case of a subsection (d) hospital that furnishes an allogeneic hematopoietic stem cell transplant to an individual during such a period, payment to such hospital for hematopoietic stem cell acquisition shall be made on a reasonable cost basis. The items included in such hematopoietic stem cell acquisition shall be specified by the Secretary through rulemaking.

“(ii) For purposes of this subparagraph, the term ‘allogeneic hematopoietic stem cell transplant’ means, with respect to an individual, the intravenous infusion of hematopoietic cells derived from bone marrow, peripheral blood stem cells, or cord blood, but not including embryonic stem cells, of a donor to an individual that are or may be used to restore hematopoietic function in such individual having an inherited or acquired deficiency or defect.”.